Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Momordica charantia | 9 | 2019 | 17 | 3.200 |
Why?
|
| Plant Extracts | 9 | 2015 | 286 | 1.790 |
Why?
|
| Morinda | 2 | 2015 | 9 | 0.940 |
Why?
|
| Hypoglycemic Agents | 2 | 2015 | 160 | 0.810 |
Why?
|
| Liver | 3 | 2011 | 479 | 0.810 |
Why?
|
| Vitamin B 12 | 1 | 2021 | 19 | 0.780 |
Why?
|
| Coffee | 1 | 2021 | 20 | 0.770 |
Why?
|
| Folic Acid | 1 | 2021 | 46 | 0.770 |
Why?
|
| Drinking | 1 | 2021 | 38 | 0.760 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2015 | 643 | 0.670 |
Why?
|
| Beverages | 2 | 2011 | 68 | 0.630 |
Why?
|
| Adipose Tissue | 2 | 2019 | 177 | 0.630 |
Why?
|
| Lipid Metabolism | 2 | 2010 | 119 | 0.600 |
Why?
|
| Kava | 2 | 2007 | 6 | 0.530 |
Why?
|
| Lactones | 2 | 2007 | 22 | 0.530 |
Why?
|
| Pyridones | 2 | 2007 | 40 | 0.510 |
Why?
|
| Alkaloids | 2 | 2007 | 39 | 0.510 |
Why?
|
| Forkhead Transcription Factors | 2 | 2011 | 76 | 0.480 |
Why?
|
| Phytotherapy | 2 | 2011 | 81 | 0.470 |
Why?
|
| Oxidative Stress | 2 | 2011 | 938 | 0.450 |
Why?
|
| Dietary Fats | 2 | 2011 | 119 | 0.440 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2013 | 110 | 0.420 |
Why?
|
| Gluconeogenesis | 1 | 2011 | 10 | 0.410 |
Why?
|
| Glycolysis | 1 | 2011 | 68 | 0.390 |
Why?
|
| Obesity | 3 | 2021 | 1067 | 0.380 |
Why?
|
| Encephalitis | 1 | 2011 | 42 | 0.380 |
Why?
|
| Cucurbitaceae | 2 | 2013 | 5 | 0.380 |
Why?
|
| Adipogenesis | 1 | 2010 | 12 | 0.370 |
Why?
|
| Plant Preparations | 1 | 2010 | 27 | 0.360 |
Why?
|
| Genes, cdc | 1 | 2010 | 8 | 0.360 |
Why?
|
| Adipocytes | 1 | 2010 | 58 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 1609 | 0.350 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 131 | 0.350 |
Why?
|
| Anticarcinogenic Agents | 1 | 2010 | 65 | 0.350 |
Why?
|
| Apolipoproteins B | 2 | 2006 | 18 | 0.320 |
Why?
|
| Apolipoprotein B-100 | 1 | 2008 | 7 | 0.320 |
Why?
|
| Receptor, Insulin | 1 | 2008 | 25 | 0.310 |
Why?
|
| Transcription Factors | 2 | 2010 | 681 | 0.300 |
Why?
|
| Carrier Proteins | 2 | 2010 | 305 | 0.300 |
Why?
|
| RNA, Messenger | 5 | 2011 | 1207 | 0.290 |
Why?
|
| Animals | 12 | 2019 | 15081 | 0.280 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2007 | 92 | 0.280 |
Why?
|
| HIV Protease Inhibitors | 1 | 2006 | 23 | 0.280 |
Why?
|
| Random Allocation | 3 | 2011 | 139 | 0.270 |
Why?
|
| Apoptosis | 3 | 2011 | 1398 | 0.260 |
Why?
|
| Microsomes | 1 | 2005 | 52 | 0.260 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2006 | 145 | 0.240 |
Why?
|
| Acidosis, Lactic | 1 | 2003 | 4 | 0.240 |
Why?
|
| Liver Neoplasms | 1 | 2006 | 190 | 0.230 |
Why?
|
| Cell Line, Tumor | 6 | 2013 | 2231 | 0.230 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 190 | 0.230 |
Why?
|
| West Nile Fever | 2 | 2014 | 56 | 0.210 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2003 | 221 | 0.210 |
Why?
|
| West Nile virus | 2 | 2014 | 65 | 0.210 |
Why?
|
| Humans | 14 | 2021 | 37093 | 0.210 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2015 | 112 | 0.190 |
Why?
|
| Mice | 7 | 2014 | 5913 | 0.180 |
Why?
|
| Male | 7 | 2021 | 20025 | 0.180 |
Why?
|
| Neoplasms | 1 | 2010 | 1103 | 0.180 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 242 | 0.170 |
Why?
|
| Female | 7 | 2021 | 20969 | 0.170 |
Why?
|
| Fruit | 2 | 2011 | 173 | 0.170 |
Why?
|
| Panniculitis | 1 | 2019 | 2 | 0.170 |
Why?
|
| Phenotype | 2 | 2021 | 689 | 0.170 |
Why?
|
| Freeze Drying | 1 | 2019 | 27 | 0.170 |
Why?
|
| Adipokines | 1 | 2019 | 24 | 0.170 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 2721 | 0.170 |
Why?
|
| Body Weight | 2 | 2019 | 434 | 0.170 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 1502 | 0.160 |
Why?
|
| Superoxide Dismutase | 2 | 2011 | 155 | 0.160 |
Why?
|
| Overweight | 1 | 2021 | 247 | 0.160 |
Why?
|
| Colon | 1 | 2019 | 103 | 0.160 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 147 | 0.150 |
Why?
|
| Caspases | 2 | 2010 | 147 | 0.140 |
Why?
|
| Body Mass Index | 1 | 2021 | 854 | 0.140 |
Why?
|
| Adolescent | 3 | 2021 | 5363 | 0.140 |
Why?
|
| Young Adult | 2 | 2021 | 4268 | 0.140 |
Why?
|
| Brain | 3 | 2014 | 1346 | 0.140 |
Why?
|
| Dietary Supplements | 2 | 2011 | 208 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1015 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 935 | 0.130 |
Why?
|
| Macrophages | 1 | 2019 | 439 | 0.130 |
Why?
|
| DNA Primers | 2 | 2006 | 286 | 0.130 |
Why?
|
| Plant Leaves | 2 | 2007 | 124 | 0.130 |
Why?
|
| Cytochrome P-450 CYP1A2 | 2 | 2007 | 28 | 0.130 |
Why?
|
| Biological Products | 1 | 2015 | 71 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2013 | 8 | 0.120 |
Why?
|
| Leukocytes | 1 | 2014 | 72 | 0.120 |
Why?
|
| Base Sequence | 2 | 2006 | 997 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2013 | 326 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 78 | 0.110 |
Why?
|
| Middle Aged | 2 | 2021 | 10129 | 0.110 |
Why?
|
| Immunity | 1 | 2012 | 53 | 0.100 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 178 | 0.100 |
Why?
|
| Hep G2 Cells | 1 | 2011 | 51 | 0.100 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2011 | 12 | 0.100 |
Why?
|
| Treatment Outcome | 1 | 2015 | 1369 | 0.100 |
Why?
|
| Adult | 2 | 2021 | 11712 | 0.100 |
Why?
|
| Taste | 1 | 2011 | 41 | 0.100 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 32 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2011 | 61 | 0.100 |
Why?
|
| Catalase | 1 | 2011 | 109 | 0.090 |
Why?
|
| Glutathione Peroxidase | 1 | 2011 | 111 | 0.090 |
Why?
|
| Time Factors | 2 | 2007 | 1742 | 0.090 |
Why?
|
| Protein Transport | 1 | 2011 | 302 | 0.090 |
Why?
|
| Lipogenesis | 1 | 2010 | 18 | 0.090 |
Why?
|
| RNA Interference | 1 | 2011 | 243 | 0.090 |
Why?
|
| Phenols | 1 | 2011 | 80 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 173 | 0.090 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 41 | 0.090 |
Why?
|
| Cytokines | 1 | 2014 | 602 | 0.090 |
Why?
|
| Vegetables | 1 | 2011 | 147 | 0.090 |
Why?
|
| G2 Phase | 1 | 2010 | 29 | 0.090 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2010 | 32 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 1371 | 0.090 |
Why?
|
| Enzyme Induction | 2 | 2007 | 53 | 0.090 |
Why?
|
| Blood-Brain Barrier | 1 | 2011 | 162 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 85 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2011 | 353 | 0.080 |
Why?
|
| Cell Division | 1 | 2010 | 307 | 0.080 |
Why?
|
| Phosphoproteins | 1 | 2010 | 163 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2010 | 444 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2011 | 661 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 623 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2011 | 928 | 0.080 |
Why?
|
| Neuroprotective Agents | 1 | 2011 | 245 | 0.080 |
Why?
|
| Apolipoprotein B-48 | 1 | 2008 | 7 | 0.080 |
Why?
|
| Antioxidants | 1 | 2011 | 416 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 229 | 0.080 |
Why?
|
| Rhizome | 1 | 2007 | 2 | 0.070 |
Why?
|
| Cytochromes | 1 | 2007 | 4 | 0.070 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2007 | 16 | 0.070 |
Why?
|
| Mitochondria, Liver | 1 | 2007 | 17 | 0.070 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2007 | 17 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2010 | 587 | 0.070 |
Why?
|
| Apolipoprotein C-III | 1 | 2006 | 5 | 0.070 |
Why?
|
| Diet | 2 | 2011 | 801 | 0.070 |
Why?
|
| Rats, Inbred F344 | 1 | 2007 | 245 | 0.070 |
Why?
|
| Apolipoprotein A-I | 1 | 2006 | 21 | 0.070 |
Why?
|
| Glutathione | 1 | 2007 | 179 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2008 | 184 | 0.070 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 129 | 0.060 |
Why?
|
| Oleic Acid | 1 | 2005 | 19 | 0.060 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2005 | 10 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 25 | 0.060 |
Why?
|
| Cytosol | 1 | 2005 | 93 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 356 | 0.060 |
Why?
|
| Reactive Oxygen Species | 1 | 2007 | 461 | 0.060 |
Why?
|
| Plant Stems | 1 | 2004 | 10 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2007 | 513 | 0.060 |
Why?
|
| Pyrones | 1 | 2004 | 9 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2003 | 49 | 0.060 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2003 | 57 | 0.060 |
Why?
|
| Nucleosides | 1 | 2003 | 30 | 0.060 |
Why?
|
| Membrane Potentials | 1 | 2003 | 223 | 0.060 |
Why?
|
| Lactic Acid | 1 | 2003 | 95 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 227 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2005 | 366 | 0.060 |
Why?
|
| Arylamine N-Acetyltransferase | 1 | 2002 | 27 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 196 | 0.050 |
Why?
|
| Meat | 1 | 2002 | 43 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 935 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 539 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1039 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2014 | 617 | 0.050 |
Why?
|
| Mitochondria | 1 | 2003 | 487 | 0.040 |
Why?
|
| Aged | 1 | 2011 | 6741 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2005 | 807 | 0.040 |
Why?
|
| Rats | 1 | 2007 | 3483 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 628 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2002 | 441 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1198 | 0.040 |
Why?
|
| Smoking | 1 | 2002 | 940 | 0.030 |
Why?
|
| Receptors, Leptin | 1 | 2014 | 13 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 75 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2014 | 121 | 0.030 |
Why?
|
| Spleen | 1 | 2014 | 199 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 259 | 0.030 |
Why?
|
| Antibody Formation | 1 | 2012 | 74 | 0.030 |
Why?
|
| Interferon-alpha | 1 | 2012 | 43 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 68 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2012 | 42 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 97 | 0.030 |
Why?
|
| Species Specificity | 1 | 2012 | 245 | 0.030 |
Why?
|
| Chemokines | 1 | 2012 | 97 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 661 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 108 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 325 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 360 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2011 | 224 | 0.020 |
Why?
|
| Viral Load | 1 | 2012 | 312 | 0.020 |
Why?
|
| Kinetics | 1 | 2012 | 708 | 0.020 |
Why?
|
| Cell Movement | 1 | 2014 | 571 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2012 | 262 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2011 | 502 | 0.020 |
Why?
|
| Virus Replication | 1 | 2012 | 278 | 0.020 |
Why?
|
| Prostate | 1 | 2011 | 154 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 859 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 601 | 0.020 |
Why?
|
| Neurons | 1 | 2014 | 1175 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 1908 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2002 | 118 | 0.010 |
Why?
|
| Registries | 1 | 2002 | 335 | 0.010 |
Why?
|
| Genotype | 1 | 2002 | 730 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 1130 | 0.010 |
Why?
|
| Hawaii | 1 | 2002 | 1929 | 0.010 |
Why?
|
| Risk Factors | 1 | 2002 | 3562 | 0.010 |
Why?
|